Department of Ophthalmology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Department of Ophthalmology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
PLoS One. 2021 Dec 14;16(12):e0261320. doi: 10.1371/journal.pone.0261320. eCollection 2021.
The present study aimed to evaluate the clinical characteristics of exudative age-related macular degeneration (AMD) in Japanese patients over a 10-year period and to compare the past our report.
We retrospectively reviewed 1,600 treatment-naïve patients (1,777 eyes) with exudative AMD. The 10 years were divided into 2-year phases I to V.
Of the 1,600 patients, 720 (45.0%), 733 (45.8%), 98 (6.1%), and 49 (3.1%) were diagnosed with typical AMD, polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation, and combined subtypes, respectively. The prevalence of PCV decreased from 54.7% in phase I to 46.0% at phase V. Of the 1,777 eyes, the mean baseline logarithm of the minimum angle of resolution best-corrected visual acuities (BCVAs) in phases I, II, III, IV, and V were 0.70, 0.66, 0.55, 0.50, and 0.48, respectively. Phases III, IV, and V had significantly (P = 0.0012, P<0.0001, P<0.0001, respectively) better baseline VAs compared with phase I. The mean lesion sizes in phases I, II, III, IV, and V were 8.6, 6.7, 5.3, 5.7, and 5.7 Macular Photocoagulation Study disc areas, respectively. The sizes were significantly (P<0.0001 for all comparisons) smaller in phases III, IV, and V compared with phase I.
Although the prevalence of PCV decreased from 54.7% in phase I to 46.0% at phase V, PCV has nevertheless been highly prevalent in Japanese patients with AMD compared with Caucasian patients. The annual better baseline VAs and smaller lesion sizes over time might be related to development of treatment and better concerns about AMD.
本研究旨在评估 10 年间日本渗出型年龄相关性黄斑变性(AMD)患者的临床特征,并与既往报告进行比较。
我们回顾性分析了 1600 例未经治疗的渗出型 AMD 患者(1777 只眼)的资料。这 10 年分为 5 个 2 年阶段(I 至 V 期)。
1600 例患者中,720 例(45.0%)、733 例(45.8%)、98 例(6.1%)和 49 例(3.1%)分别被诊断为典型 AMD、息肉样脉络膜血管病变(PCV)、视网膜血管性增殖和混合型。PCV 的患病率从 I 期的 54.7%降至 V 期的 46.0%。1777 只眼中,I、II、III、IV 和 V 期基线最小分辨角对数视力(BCVA)的平均对数分别为 0.70、0.66、0.55、0.50 和 0.48。III、IV 和 V 期与 I 期相比,基线视力明显更好(P = 0.0012、P<0.0001、P<0.0001)。I、II、III、IV 和 V 期病变平均大小分别为 8.6、6.7、5.3、5.7 和 5.7 个 Macular Photocoagulation Study 盘区。与 I 期相比,III、IV 和 V 期病变大小明显更小(所有比较均 P<0.0001)。
尽管 PCV 的患病率从 I 期的 54.7%降至 V 期的 46.0%,但与高加索 AMD 患者相比,PCV 在日本 AMD 患者中仍高度流行。随着时间的推移,每年基线视力的改善和病变大小的缩小可能与治疗的发展和对 AMD 的更好关注有关。